HomeNewsBusinessCoronavirus impact | IndiGo cuts salaries, CEO Ronojoy Dutta to take home 25% lesser pay

Coronavirus impact | IndiGo cuts salaries, CEO Ronojoy Dutta to take home 25% lesser pay

"With a great deal of reluctance and a deep sense of regret we are, therefore, instituting pay cuts for all employees excluding bands A and B, starting April 1," the airline said in a letter.

March 19, 2020 / 17:55 IST
Story continues below Advertisement

Due to the 'precipitous drop in revenues' domestic airline IndiGo has announced that it will cut employee salaries, including that of the CEO Ronojoy, by up to 25 percent starting April 1, 2020, the airline's CEO told employees in a mail.

Moneycontrol has seen a copy of the mail sent on March 19.

Story continues below Advertisement

In the mail, Dutta said, "With the precipitous drop in revenues, the very survival of the airline industry is now at stake. We have to pay careful attention to our cash flow so that we do not run out of cash."

This, he added, means that there is a need to reduce costs in line with the drop in revenues.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show